Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs

Lang K, Drell TL t., Lindecke A, Niggemann B, Zaenker KS, Entschladen F, Kaltschmidt C (2004)
Int J Cancer 112 112(2): 231-238.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Lang, K.; Drell, T. L. t.; Lindecke, A.; Niggemann, B.; Zaenker, K. S.; Entschladen, F.; Kaltschmidt, ChristianUniBi
Int J Cancer 112
Page URI


Lang K, Drell TL t., Lindecke A, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112. 2004;112(2):231-238.
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., & Kaltschmidt, C. (2004). Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112, 112(2), 231-238.
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., and Kaltschmidt, Christian. 2004. “Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs”. Int J Cancer 112 112 (2): 231-238.
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., and Kaltschmidt, C. (2004). Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112 112, 231-238.
Lang, K., et al., 2004. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112, 112(2), p 231-238.
K. Lang, et al., “Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs”, Int J Cancer 112, vol. 112, 2004, pp. 231-238.
Lang, K., Drell, T.L. t., Lindecke, A., Niggemann, B., Zaenker, K.S., Entschladen, F., Kaltschmidt, C.: Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112. 112, 231-238 (2004).
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., and Kaltschmidt, Christian. “Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs”. Int J Cancer 112 112.2 (2004): 231-238.

114 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Effects of β-Adrenergic Antagonists on Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Chaudhary KR, Yan SX, Heilbroner SP, Sonett JR, Stoopler MB, Shu C, Halmos B, Wang TJC, Hei TK, Cheng SK., J Clin Med 8(5), 2019
PMID: 31035526
The prognostic value of ADRA1 subfamily genes in gastric carcinoma.
Wang T, Qin Y, Lai H, Wei W, Li Z, Yang Y, Huang M, Chen J., Oncol Lett 18(3), 2019
PMID: 31452791
Influence of the neural microenvironment on prostate cancer.
Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, Ragheb A, Frolov A, Michailidis G, Lee M, Kadmon D, Miles B, Smith C, Ittmann M, Rowley D, Sreekumar A, Creighton CJ, Ayala G., Prostate 78(2), 2018
PMID: 29131367
Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment.
Kumar N, Prasad P, Jash E, Saini M, Husain A, Goldman A, Sehrawat S., Mol Cell Biochem 447(1-2), 2018
PMID: 29417338
Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember.
Solomon I, Voiculescu VM, Caruntu C, Lupu M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C, Neagu M, Boda D., Dis Markers 2018(), 2018
PMID: 29854027
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.
Hwa YL, Shi Q, Kumar SK, Lacy MQ, Gertz MA, Kapoor P, Buadi FK, Leung N, Dingli D, Go RS, Hayman SR, Gonsalves WI, Russell S, Lust JA, Lin Y, Rajkumar SV, Dispenzieri A., Am J Hematol 92(1), 2017
PMID: 27733010
Protective Role of the Hepatic Vagus Nerve against Liver Metastasis in Mice.
Hiramoto T, Yoshihara K, Asano Y, Sudo N., Neuroimmunomodulation 24(6), 2017
PMID: 29621768
Accelerated tumor growth under intermittent hypoxia is associated with hypoxia-inducible factor-1-dependent adaptive responses to hypoxia.
Yoon DW, So D, Min S, Kim J, Lee M, Khalmuratova R, Cho CH, Park JW, Shin HW., Oncotarget 8(37), 2017
PMID: 28977888
Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
Jansen L, Weberpals J, Kuiper JG, Vissers PAJ, Wolkewitz M, Hoffmeister M, Brenner H., Int J Cancer 141(1), 2017
PMID: 28370155
Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.
Kim SH, Cho KH, Kim YN, Jeong BY, Park CG, Hur GM, Lee HY., Arch Pharm Res 39(2), 2016
PMID: 26428673
Prognostic significance of β2-adrenergic receptor expression in malignant melanoma.
Shimizu A, Kaira K, Mori K, Kato M, Shimizu K, Yasuda M, Takahashi A, Oyama T, Asao T, Ishikawa O., Tumour Biol 37(5), 2016
PMID: 26596834
Re-Use of Established Drugs for Anti-Metastatic Indications.
Entschladen F, Thyssen DA, Drell DW., Cells 5(1), 2016
PMID: 26771645
Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14.
Li J, Zeng Q, Zhang Y, Li X, Hu H, Miao X, Yang W, Zhang W, Song X, Mou L, Wang R., Eur J Cell Biol 95(10), 2016
PMID: 27498853
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.
Pantziarka P, Bouche G, Sukhatme V, Meheus L, Rooman I, Sukhatme VP., Ecancermedicalscience 10(), 2016
PMID: 27899953
Propranolol enhances bone healing and implant osseointegration in rats tibiae.
Al-Subaie AE, Laurenti M, Abdallah MN, Tamimi I, Yaghoubi F, Eimar H, Makhoul N, Tamimi F., J Clin Periodontol 43(12), 2016
PMID: 27706837
Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
Cardwell CR, Pottegård A, Vaes E, Garmo H, Murray LJ, Brown C, Vissers PA, O'Rorke M, Visvanathan K, Cronin-Fenton D, De Schutter H, Lambe M, Powe DG, van Herk-Sukel MP, Gavin A, Friis S, Sharp L, Bennett K., Breast Cancer Res 18(1), 2016
PMID: 27906047
Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
Filippi L, Dal Monte M, Casini G, Daniotti M, Sereni F, Bagnoli P., Med Res Rev 35(3), 2015
PMID: 25523517
The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.
Munoz M, Covenas R, Esteban F, Redondo M., J Biosci 40(2), 2015
PMID: 25963269
The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.
Barbieri A, Bimonte S, Palma G, Luciano A, Rea D, Giudice A, Scognamiglio G, La Mantia E, Franco R, Perdonà S, De Cobelli O, Ferro M, Zappavigna S, Stiuso P, Caraglia M, Arra C., Int J Oncol 47(2), 2015
PMID: 26058426
β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.
Wilson JM, Lorimer E, Tyburski MD, Williams CL., Cancer Biol Ther 16(9), 2015
PMID: 26209110
Sympathetic nervous system regulation of the tumour microenvironment.
Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK., Nat Rev Cancer 15(9), 2015
PMID: 26299593
β-Adrenergic Receptor Signaling in Prostate Cancer.
Braadland PR, Ramberg H, Grytli HH, Taskén KA., Front Oncol 4(), 2014
PMID: 25629002
Mechanisms of propranolol action in infantile hemangioma.
Kum JJ, Khan ZA., Dermatoendocrinol 6(1), 2014
PMID: 26413184
Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L, Hoffmeister M, Arndt V, Chang-Claude J, Brenner H., Cancer 120(8), 2014
PMID: 24415516
Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
González-Ortega A, Sánchez-Vaderrábanos E, Ramiro-Fuentes S, Salinas-Martín MV, Carranza A, Coveñas R, Muñoz M., Peptides 55(), 2014
PMID: 24548567
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS., Breast Cancer Res Treat 144(2), 2014
PMID: 24557337
Involvement of substance P and the NK-1 receptor in pancreatic cancer.
Muñoz M, Coveñas R., World J Gastroenterol 20(9), 2014
PMID: 24605029
Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study.
McCourt C, Coleman HG, Murray LJ, Cantwell MM, Dolan O, Powe DG, Cardwell CR., Br J Dermatol 170(4), 2014
PMID: 24593055
Involvement of substance P and the NK-1 receptor in human pathology.
Muñoz M, Coveñas R., Amino Acids 46(7), 2014
PMID: 24705689
Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Cardwell CR, Coleman HG, Murray LJ, O'Sullivan JM, Powe DG., Cancer Epidemiol 38(3), 2014
PMID: 24786858
Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.
Wu JW, Boudreau DM, Park Y, Simonds NI, Freedman AN., Expert Opin Drug Saf 13(8), 2014
PMID: 24999107
beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration.
Işeri OD, Sahin FI, Terzi YK, Yurtcu E, Erdem SR, Sarialioglu F., Pharm Biol 52(11), 2014
PMID: 25026350
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Muñoz M, González-Ortega A, Salinas-Martín MV, Carranza A, Garcia-Recio S, Almendro V, Coveñas R., Int J Oncol 45(4), 2014
PMID: 25175857
Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
Assayag J, Pollak MN, Azoulay L., Eur J Cancer 50(16), 2014
PMID: 25204805
Psychosocial stress and inflammation in cancer.
Powell ND, Tarr AJ, Sheridan JF., Brain Behav Immun 30 Suppl(), 2013
PMID: 22790082
Nervous system regulation of the cancer genome.
Cole SW., Brain Behav Immun 30 Suppl(), 2013
PMID: 23207104
β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice.
Spindler SR, Mote PL, Li R, Dhahbi JM, Yamakawa A, Flegal JM, Jeske DR, Li R, Lublin AL., Age (Dordr) 35(6), 2013
PMID: 23314750
Effect of chronic restraint stress on human colorectal carcinoma growth in mice.
Lin Q, Wang F, Yang R, Zheng X, Gao H, Zhang P., PLoS One 8(4), 2013
PMID: 23585898
Norepinephrine inhibits the migratory activity of pancreatic cancer cells.
Stock AM, Powe DG, Hahn SA, Troost G, Niggemann B, Zänker KS, Entschladen F., Exp Cell Res 319(12), 2013
PMID: 23639786
Safety of neurokinin-1 receptor antagonists.
Muñoz M, Coveñas R., Expert Opin Drug Saf 12(5), 2013
PMID: 23706125
Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y, Zhao L, Xiong T, Chen X, Zhang Y, Yu M, Yang J, Yao Z., Breast Cancer Res Treat 140(1), 2013
PMID: 23807418
β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Nijsten T, Schadendorf D, de Vries E., Eur J Cancer 49(18), 2013
PMID: 23942335
Central and peripheral nervous systems: master controllers in cancer metastasis.
Shi M, Liu D, Yang Z, Guo N., Cancer Metastasis Rev 32(3-4), 2013
PMID: 23674223
Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
Cardwell CR, Coleman HG, Murray LJ, Entschladen F, Powe DG., Int J Epidemiol 42(6), 2013
PMID: 24536096
Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study.
Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Gayoso-Diz P, Otero-Rey EM, Gándra-Rey JM, García-García A., Biotech Histochem 87(3), 2012
PMID: 21916780
Molecular pathways: beta-adrenergic signaling in cancer.
Cole SW, Sood AK., Clin Cancer Res 18(5), 2012
PMID: 22186256
Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.
Boulay G, Malaquin N, Loison I, Foveau B, Van Rechem C, Rood BR, Pourtier A, Leprince D., J Biol Chem 287(8), 2012
PMID: 22194601
The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.
Rosso M, Muñoz M, Berger M., ScientificWorldJournal 2012(), 2012
PMID: 22545017
Beta-adrenergic blocking drugs in breast cancer: a perspective review.
Barron TI, Sharp L, Visvanathan K., Ther Adv Med Oncol 4(3), 2012
PMID: 22590485
The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W., Ann Surg Oncol 19(11), 2012
PMID: 22588469
NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.
Muñoz M, Martinez-Armesto J, Coveñas R., Expert Opin Ther Pat 22(7), 2012
PMID: 22697287
β-blockers: a novel class of antitumor agents.
Ji Y, Chen S, Xiao X, Zheng S, Li K., Onco Targets Ther 5(), 2012
PMID: 23226026
Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition.
Barros PO, Ferreira TB, Vieira MM, Almeida CR, Araújo-Lima CF, Silva-Filho RG, Hygino J, Andrade RM, Andrade AF, Bento CA., J Clin Immunol 31(1), 2011
PMID: 20865305
Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism.
Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, Kim YK, Kang J, Park CG, Lee HY., Int J Cancer 128(10), 2011
PMID: 20715173
Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Powe DG, Voss MJ, Habashy HO, Zänker KS, Green AR, Ellis IO, Entschladen F., Breast Cancer Res Treat 130(2), 2011
PMID: 21298476
Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.
Voss MJ, Möller MF, Powe DG, Niggemann B, Zänker KS, Entschladen F., BMC Cancer 11(), 2011
PMID: 21535870
The neuronal influence on tumor progression.
Mancino M, Ametller E, Gascón P, Almendro V., Biochim Biophys Acta 1816(2), 2011
PMID: 21616127
NK-1 as a melanoma target.
Muñoz M, Bernabeu-Wittel J, Coveñas R., Expert Opin Ther Targets 15(7), 2011
PMID: 21592000
Expanding our therapeutic options: Beta blockers for breast cancer?
Ganz PA, Cole SW., J Clin Oncol 29(19), 2011
PMID: 21632500
Beta blockers and breast cancer mortality: a population- based study.
Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K., J Clin Oncol 29(19), 2011
PMID: 21632503
Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor.
Brimson JM, Brown CA, Safrany ST., Br J Pharmacol 164(2b), 2011
PMID: 21486275
The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
Muñoz M, Rosso M., Invest New Drugs 28(2), 2010
PMID: 19148578
The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines.
Muñoz M, Rosso M, Robles-Frias MJ, Salinas-Martín MV, Rosso R, González-Ortega A, Coveñas R., Lab Invest 90(8), 2010
PMID: 20458280
SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D.
Huang WQ, Wang JG, Chen L, Wei HJ, Chen H., J Exp Clin Cancer Res 29(), 2010
PMID: 20497542
Tumor interactions with soluble factors and the nervous system.
Voss MJ, Entschladen F., Cell Commun Signal 8(), 2010
PMID: 20822525
The sympathetic nervous system induces a metastatic switch in primary breast cancer.
Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, Sood AK, Cole SW., Cancer Res 70(18), 2010
PMID: 20823155
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, Sood AK., J Biol Chem 285(46), 2010
PMID: 20826776
Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
Powe DG, Voss MJ, Zänker KS, Habashy HO, Green AR, Ellis IO, Entschladen F., Oncotarget 1(7), 2010
PMID: 21317458
Impact of stress on cancer metastasis.
Moreno-Smith M, Lutgendorf SK, Sood AK., Future Oncol 6(12), 2010
PMID: 21142861
The inhibitory effect of norepinephrine on the migration of ES-2 ovarian carcinoma cells involves a Rap1-dependent pathway.
Bastian P, Balcarek A, Altanis C, Strell C, Niggemann B, Zaenker KS, Entschladen F., Cancer Lett 274(2), 2009
PMID: 18849110
Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ, Liu K, Liang DF., J Oral Pathol Med 38(4), 2009
PMID: 19141064
Is norepinephrine an etiological factor in some types of cancer?
Fitzgerald PJ., Int J Cancer 124(2), 2009
PMID: 19004004
Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes.
Strell C, Sievers A, Bastian P, Lang K, Niggemann B, Zänker KS, Entschladen F., BMC Immunol 10(), 2009
PMID: 19968887
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
Muñoz M, Rosso M, Aguilar FJ, González-Moles MA, Redondo M, Esteban F., Invest New Drugs 26(2), 2008
PMID: 17906845
Neuroendocrine influences on cancer biology.
Thaker PH, Sood AK., Semin Cancer Biol 18(3), 2008
PMID: 18201896
The cancer's nervous tooth: Considering the neuronal crosstalk within tumors.
Entschladen F, Palm D, Niggemann B, Zaenker KS., Semin Cancer Biol 18(3), 2008
PMID: 18249004
Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma.
Schuller HM, Al-Wadei HA, Majidi M., Carcinogenesis 29(10), 2008
PMID: 18310090
Neurotransmission and cancer: implications for prevention and therapy.
Schuller HM., Anticancer Drugs 19(7), 2008
PMID: 18594207
N-cadherin engagement provides a dominant stop signal for the migration of MDA-MB-468 breast carcinoma cells.
Potthoff S, Entschladen F, Niggemann B, Zaenker KS, Lang K., Breast Cancer Res Treat 105(3), 2007
PMID: 17171299
The significance of substance P in physiological and malignant haematopoiesis.
Nowicki M, Ostalska-Nowicka D, Kondraciuk B, Miskowiak B., J Clin Pathol 60(7), 2007
PMID: 17172475
Tumor immune escape mechanisms: impact of the neuroendocrine system.
Lang K, Entschladen F, Weidt C, Zaenker KS., Cancer Immunol Immunother 55(7), 2006
PMID: 16435128
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.
Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK., Nat Rev Cancer 6(3), 2006
PMID: 16498446
Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
Erin N, Zhao W, Bylander J, Chase G, Clawson G., Breast Cancer Res Treat 99(3), 2006
PMID: 16583263
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.
Palm D, Lang K, Niggemann B, Drell TL, Masur K, Zaenker KS, Entschladen F., Int J Cancer 118(11), 2006
PMID: 16381019
DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma.
Li L, Miyamoto M, Ebihara Y, Mega S, Takahashi R, Hase R, Kaneko H, Kadoya M, Itoh T, Shichinohe T, Hirano S, Kondo S., World J Surg 30(9), 2006
PMID: 16850143
Targeting key steps in metastatic tumour progression.
Eccles SA., Curr Opin Genet Dev 15(1), 2005
PMID: 15661537
Psychological stress induces chemoresistance in breast cancer by upregulating mdr1.
Su F, Ouyang N, Zhu P, Ouyang N, Jia W, Gong C, Ma X, Xu H, Song E., Biochem Biophys Res Commun 329(3), 2005
PMID: 15752739
The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
Muñoz M, Rosso M, Pérez A, Coveñas R, Rosso R, Zamarriego C, Piruat JI., Neuropeptides 39(4), 2005
PMID: 15939468
In vitro and in vivo imaging of cell migration: two interdepending methods to unravel metastasis formation.
Palm D, Lang K, Brandt B, Zaenker KS, Entschladen F., Semin Cancer Biol 15(5), 2005
PMID: 16054391

48 References

Daten bereitgestellt von Europe PubMed Central.

Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.
Entschladen F, Drell TL 4th, Lang K, Joseph J, Zaenker KS., Lancet Oncol. 5(4), 2004
PMID: 15050959
Neurotransmitters are regulators for the migration of tumor cells and leukocytes.
Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS., Cancer Immunol. Immunother. 51(9), 2002
PMID: 12357318
Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop.
Lang K, Niggemann B, Zanker KS, Entschladen F., Int. J. Cancer 99(5), 2002
PMID: 12115500
Involvement of chemokine receptors in breast cancer metastasis.
Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A., Nature 410(6824), 2001
PMID: 11242036
Examining psychosocial factors related to cancer incidence and progression: in search of the silver lining.
Heffner KL, Loving TJ, Robles TF, Kiecolt-Glaser JK., Brain Behav. Immun. 17 Suppl 1(), 2003
PMID: 12615195
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells.
Drell TL 4th, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F., Breast Cancer Res. Treat. 80(1), 2003
PMID: 12889599

Niggemann, Exp Cell Res (), 2004
A new role for GABA: inhibition of tumor cell migration.
Ortega A., Trends Pharmacol. Sci. 24(4), 2003
PMID: 12706998
High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells.
Masur K, Lang K, Niggemann B, Zanker KS, Entschladen F., Mol. Biol. Cell 12(7), 2001
PMID: 11451996
Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers.
Masur K, Niggemann B, Zanker KS, Entschladen F., Cancer Res. 61(7), 2001
PMID: 11306460
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
Bochkov VN, Kadl A, Huber J, Gruber F, Binder BR, Leitinger N., Nature 419(6902), 2002
PMID: 12214235
Evaluation and optimization of procedures for target labeling and hybridization of cDNA microarrays.
Yu J, Othman MI, Farjo R, Zareparsi S, MacNee SP, Yoshida S, Swaroop A., Mol. Vis. 8(), 2002
PMID: 12011805
Psychosocial factors in the development and progression of breast cancer.
Hilakivi-Clarke L, Rowland J, Clarke R, Lippman ME., Breast Cancer Res. Treat. 29(2), 1994
PMID: 8012033
Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors.
Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, Akechi T, Uchitomi Y., Breast Cancer Res. Treat. 61(2), 2000
PMID: 10942098
Neurobiology of substance P and the NK1 receptor.
Mantyh PW., J Clin Psychiatry 63 Suppl 11(), 2002
PMID: 12562137
Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).
Santarelli L, Gobbi G, Blier P, Hen R., J Clin Psychiatry 63 Suppl 11(), 2002
PMID: 12562138
Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat.
Gresch PJ, Sved AF, Zigmond MJ, Finlay JM., J. Neurochem. 63(2), 1994
PMID: 8035182
Norepinephrine-induced phosphorylation of the transcription factor CREB in isolated rat pinealocytes: an immunocytochemical study.
Tamotsu S, Schomerus C, Stehle JH, Roseboom PH, Korf HW., Cell Tissue Res. 282(2), 1995
PMID: 8565052
Calcium regulation of neuronal gene expression.
West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME., Proc. Natl. Acad. Sci. U.S.A. 98(20), 2001
PMID: 11572963
Norepinephrine increases I kappa B alpha expression in astrocytes.
Gavrilyuk V, Dello Russo C, Heneka MT, Pelligrino D, Weinberg G, Feinstein DL., J. Biol. Chem. 277(33), 2002
PMID: 12050158
Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells.
Vertegaal AC, Kuiperij HB, Yamaoka S, Courtois G, van der Eb AJ, Zantema A., Cell. Signal. 12(11-12), 2000
PMID: 11152962
Transcription factor CREB and its stimulus-dependent phosphorylation in cell and explant cultures of the bovine subcommissural organ.
Schoniger S, Maronde E, Kopp MD, Korf HW, Nurnberger F., Cell Tissue Res. 308(1), 2002
PMID: 12012213
Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation.
Brami-Cherrier K, Valjent E, Garcia M, Pages C, Hipskind RA, Caboche J., J. Neurosci. 22(20), 2002
PMID: 12388598
Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells.
Bergquist J, Ohlsson B, Tarkowski A., Ann. N. Y. Acad. Sci. 917(), 2000
PMID: 11268354
Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.
Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ., J. Neuroimmunol. 131(1-2), 2002
PMID: 12458047
AP-1: one switch for many signals.
Wisdom R., Exp. Cell Res. 253(1), 1999
PMID: 10579922
Gene transcription through activation of G-protein-coupled chemoattractant receptors.
Ye RD, Pan Z, Kravchenko VV, Browning DD, Prossnitz ER., Gene Expr. 5(4-5), 1996
PMID: 8723387
Seven-transmembrane receptors.
Pierce KL, Premont RT, Lefkowitz RJ., Nat. Rev. Mol. Cell Biol. 3(9), 2002
PMID: 12209124
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ., Science 283(5402), 1999
PMID: 9924018
Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
Fujita H, Okada F, Hamada J, Hosokawa M, Moriuchi T, Koya RC, Kuzumaki N., Int. J. Cancer 93(6), 2001
PMID: 11519036
Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A., Cancer 95(6), 2002
PMID: 12216092
Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapaa H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A., Urology 61(4), 2003
PMID: 12670587
MARCKS: a case of molecular exaptation?
Ramsden JJ., Int. J. Biochem. Cell Biol. 32(5), 2000
PMID: 10736562
MARCKS functions as a novel growth suppressor in cells of melanocyte origin.
Brooks G, Brooks SF, Goss MW., Carcinogenesis 17(4), 1996
PMID: 8625478
A genetic model for colorectal tumorigenesis.
Fearon ER, Vogelstein B., Cell 61(5), 1990
PMID: 2188735

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 15352035
PubMed | Europe PMC

Suchen in

Google Scholar